The result is a peptide with a half-life of 159 to 195 hours, roughly 7 to 8 days, making once-weekly administration possible
Personalized Treatment Each therapy is tailored to the individual's specific needs, ensuring optimal results
Copper peptides offer a different mechanistic profile with a gentler side-effect profile but they aren't drop-in replacements for FDA-approved drugs
This suggests that DSIP may help protect neurons and support brain function, making it a promising candidate for therapies aimed at improving movement and coordination after stroke
233 Among the AAV family, a natural AAV9 capsid variant which was isolated from human liver tissue, has the ability to bypass BBB, becoming a star capsid for drug delivery into CNS
Nitric Oxide System Stupnisek et al